India, April 10 -- Telix Pharmaceuticals Limited (TLX) shares rose 6.90 percent, gaining $0.68 to $10.46 on Friday, after the company announced that the U.S. Food and Drug Administration accepted its resubmitted New Drug Application for TLX101-Px.
The stock is currently trading at $10.46 compared with its previous close of $9.78, after opening at $10.10 on the Nasdaq. Shares traded between $10.10 and $10.71 during the session, with volume at 195,550 shares versus an average daily volume of 247,896.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
The FDA acceptance includes a PDUFA target action date of September 11, 2026, for the investigational PET imaging agent designed to detect glioma, a form of b...